Hepatocellular carcinoma (HCC) is the leading cause of cancer-related death in people, and
a common primary liver cancer. Lacking early diagnosis and a high recurrence rate after …

The frequent metastasis of gastric cancer (GC) complicates the cure and therefore the
development of effective diagnostic and therapeutic approaches is urgently necessary. In …

Exosomes are nano-sized membrane vesicles that transfer bioactive molecules between
cells and modulate various biological processes under physiological and pathological …

The development of chemoresistance is a major hurdle for the treatment of colorectal cancer
(CRC), which contributes remarkably to the poor clinical prognosis. Nanodrug delivery …

The cancer burden continues to grow globally, and drug resistance remains a substantial
challenge in cancer therapy. It is well established that cancerous cells with clonal dysplasia …

Lenvatinib is a multikinase inhibitor which mainly hinders liver cancer proliferation by
inhibiting angiogenesis. In 2018, Lenvatinib was approved for the first-line treatment of …

Triple negative breast cancer is distinguished by its high malignancy, aggressive invasion,
rapid progression, easy recurrence, and distant metastases. Additionally, it has a poor …

Achillea millefolium Linn. is an aromatic edible plant used traditionally for the remediation of
wounds, liver disorders, and as an herbal tea for the treatment of various gastrointestinal …

Background This study aims to evaluate the efficacy and therapeutic mechanism of bufalin
on lung adenocarcinoma (LUAD) through a comprehensive strategy integrating network …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer with poor
prognosis. The incidences of HCC and HCC-related deaths have increased over the last …